RObotic Versus LAparoscopic Colectomy for DIverticulitis. (ROLADI)

January 26, 2025 updated by: Giuliani Giuseppe, S.M. Misericordia Hospital

RObotic Vs LAparoscopic Colectomy for DIverticulitis. a Multicenter Observational Prospective Study.

Over the last decade there has been a growing interest toward the application of robotic approach for diverticular disease. The evidence available on the literature showed that robotic approach, compared to the laparoscopic surgery, offers significant advantages in terms of conversion rate and shortened hospital stay for the treatment of diverticular disease.

The investigators aimed at evaluating whether robotic colectomy may offer some advantages over the laparoscopic approach for surgical treatment of diverticular disease by analyzing a one year multicenter prospective study.

Primary objective is to evaluate if robotic approach reduce the rate of conversion to open approach compared to laparoscopic surgery. Secondary objective is to assess difference between the two approaches in terms of rate of intraoperative complication, postoperative morbidities (according with Clavien and Dindo Classification), hospital stay and at one year follow up. Inclusion criteria are: elective colectomy for complicated or non-complicated diverticular disease performed with laparoscopic or robotic approach and age between 18 and 90 years. Exclusion criteria are non-elective colectomy (emergency resection), open procedure, diverticular resection performed during other procedure (i.e. colectomy for cancer). Data will be collected in one year from the start of the study.

Due to the lack of available evidence, it is impossible to draw definitive conclusions. With this study, the investigators hope to clarify the role of the robotic approach in the treatment of diverticular disease.

Study Overview

Detailed Description

Background Over the past decade, there has been a growing interest in the use of robotic surgery for diverticular disease (DD). The evidence available in the literature is based on retrospective studies and two meta-analyses1,2. To date, the robotic approach offers significant advantages over laparoscopic surgery in terms of conversion rate and shortened hospital stay for the treatment of diverticular disease.

The investigators aimed to evaluate whether elective robotic colectomy may offer some advantages over the laparoscopic approach for surgical treatment of diverticular disease performing a prospective multicenter study.

Methods and Materials This is a multi-center, prospective, not-for-profit cohort study that will enroll patients undergoing elective or delayed urgent surgical treatment for left-sided colonic diverticular disease. The enrollment period will be one year, followed by one year of follow-up. The study will start in Juin 2023.

Data will be collected in a prospective database using an easy to fill out Google form, also available on mobile devices.

Several preoperative, intraoperative and postoperative outcomes will be analyzed.

OUTCOMES Pre-Operative

  • Demographic Outcomes: Age, gender, body mass index (BMI), American Society of Anesthesiologists (ASA), Charlson Comorbidity Index (CSI: https://www.mdcalc.com/calc/3917/charlson-comorbidity-index-cci)
  • Indications for surgery:
  • Complicated DD: colonic stenosis, abscess, fistula, others;
  • Recurrent DD: multiple episodes of diverticulitis affecting quality of life;
  • Planned vascular ligation (inferior mesenteric artery vs. sigmoid arteries)
  • Preoperative bowel preparation
  • Indication for minimally invasive approach pursued (Why Rob vs Lap)

Intraoperative

  • Surgical approach (laparoscopic or robotic)
  • Intraoperative findings (sigmoid stenosis, stricture, adhesion, fistula)
  • Intraoperative complications (specify types)
  • Conversion to open approach
  • Operative times
  • Effective vessel ligation
  • Splenic flexure mobilization
  • Type of colon resection (sigmoidectomy, left colectomy, anterior rectal resection, Hartmann procedure)
  • Stoma (ileostomy vs. colostomy)
  • Associated procedures
  • Specimen extraction (midline, off midline, suprapubic or natural orifice) Postoperative
  • 30-day postoperative complications (Clavien-Dindo classification)
  • 30-day reoperation
  • 30-day readmission
  • Length of stay LOS
  • Time to return to work (days)
  • 30 days - Mortality
  • One-year follow-up

Sample size The estimated sample sizes for the study using a proportion of 0.125 for Laparoscopic approach and a proportion of 0.074 for Robotic approach, and a risk of conversion rate OR=0.56 (IC95% 0.45-0.70), is at least 1450 patients (725 for the group - alpha = 0.0500, power = 0.9000, delta = 0.5600). MICE (Multivariate Imputation via Chained Equations) is the procedure used to impute missing data for explanatory variables. In this approach, instead of imputing all missing values with a single value (mean/median), the statistical information is derived from the median), it takes into account the statistical information derived from the distribution of the other variables. The missing values are considered as an outcome to be predicted. This allows to take into account the correct variability in the entire data set and to obtain estimates that are as unbiased as possible.

Statistical Analysis The quantitative variables included in the study are expressed as mean ± standard deviation, median and range (distance between maximum and minimum values), both at the overall level and by surgical approach. The qualitative (categorical) variables are presented as percentages and absolute values, both at a general level and divided by surgical approach. It will be evaluated, if necessary, to perform a propensity score matching procedure between the two approaches (Rob and Lap), using the nearest neighbor matching technique, without replacement. Demographics, pre-operative and intra-operative characteristics are used in the propensity score logistic regression models to minimize selection bias, by assembling a matched cohort in which confounding factors are balanced between the two groups. In the matched cohort bivariate analyses are performed to .compare the primary and secondary outcomes between the two groups.

The comparison between the quantitative variables of interest is performed by the two-tailed Student T-test (in case of heteroskedasticity of variances) or with nonparametric tests, such as the Mann-Whitney U test or theKruskal-Wallis test. The comparison between qualitative variables of interest is carried out to evaluate the association or not between them, through an extension of the chi-square test suitable for multicenter studies (the Cochran - Mantel - Haenszel test).

For the entire cohort multivariate logistic regression models are performed to test the effect of surgical approach on primary and secondary outcomes.

Ethics and dissemination The trial will be conducted in accordance with the Declaration of Helsinki and in compliance with the Good Clinical Practice, Principle E6 (R2). The study will be approved by the Ethics Committee of the coordinating center (Comitato Etico di Area Vasta Sud Est Dipartimento Politiche del Farmaco e Attività Farmaceutiche Segreteria Amministrativa) and then will be registered at ClinicalTrial.gov. Subsequently, all participating centers will receive approval to participate from the local institutional review board. Authorship for written publications will be confirmed for all participating investigators (2 investigators per center). Anonymized participant-level data sets will be made available upon reasonable upon reasonable request by contacting the principal investigator. Study results will be presented at international or national meetings and published in surgical journals.

Study Type

Observational

Enrollment (Estimated)

1450

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Tuscany
      • Grosseto, Tuscany, Italy, 58100
        • Recruiting
        • Department of General and Emergency Surgery. Misericordia Hospital. Director: Coratti Andrea, MD
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients with diverticular disease of the left colon with surgical indication.

Description

Inclusion Criteria:

  • Age > 18 years
  • Elective or delayed urgency colorectal resection for left-sided DD
  • Fully minimally invasive (robotic or laparoscopic) procedures.

Exclusion Criteria:

  • Age < 18 years
  • Urgent resection for DD
  • Hybrid minimally invasive resection
  • Conventional open resection.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Robotic surgery group
Patients with diverticular disease resected with a robotic approach.
Patients are treated with a robotic approach as the standard of care for the treatment of left-sided colonic diverticular disease, depending on the experience of the surgeon or institution.
Laparoscopic surgery group
Patients with diverticular disease resected with a laparoscopic approach.
Patients are treated with a laparoscopic approach as the standard of care for the treatment of left-sided colonic diverticular disease, depending on the experience of the surgeon or institution.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Conversion rate
Time Frame: One year
The primary objective is to evaluate whether the robotic approach reduces the rate of conversion to open surgery compared to laparoscopic surgery.
One year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intra - operative complications
Time Frame: One year
The first secondary outcome measure is to assess the difference between the two approaches in terms of intra-operative complications (e.g. bleeding, spleen injury, ureteral injury, bowel perforation)
One year
Operative time
Time Frame: One year
Evaluate the possible difference in terms of operative time (expressed in minutes) between the two groups, to assess whether the robotic approach has a longer operative time than the laparoscopic approach.
One year
Complicated disease
Time Frame: One year
Evaluate the difference between the two approaches in the number of complicated cases performed. For example, analyze whether one group performs more complicated diverticular disease (e.g., colonic stenosis, colorectal fistula, intraperitoneal abscess) than the other.
One year
30 day Post - operative complications
Time Frame: One year
Another secondary outcome measure is to assess the difference between the two groups in terms of post-operative complications (using the Clavien and Dindo classification).
One year
30-day Post - operative re-operation
Time Frame: One year
Evaluate the possible difference in term of rate of re-operation between the two groups within 30 day after surgery.
One year
30-day Post - operative mortality
Time Frame: One year
Evaluate the possible difference in term of rate of mortality between the two groups within 30 day after surgery.
One year
Length of hospital stay
Time Frame: One year
Evaluate the possible difference in term of length of hospital stay (expressed in day) between the two groups.
One year
Time to return at work
Time Frame: One year
Evaluate the possible difference in time to return to work (expressed in days from surgery) between the two groups.
One year
One year follow up
Time Frame: Two years
Evaluate the possible difference in terms of disease recurrence or incisional hernia, between the two groups at one year after surgery.
Two years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2023

Primary Completion (Estimated)

March 30, 2025

Study Completion (Estimated)

June 30, 2025

Study Registration Dates

First Submitted

April 11, 2023

First Submitted That Met QC Criteria

April 23, 2023

First Posted (Actual)

April 25, 2023

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 26, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diverticulitis

Clinical Trials on Robotic left colectomy

Subscribe